| |
Nandanan Erathodiyil was born and raised in Kerala, a southern state in India. After receiving his M. Sc. Degree in chemistry from the University of Calicut, he joined the National Chemical Laboratory, Pune, in 1992 as a CSIR research fellow and received his Ph. D. degree (organic chemistry) in 1997 under the supervision of Dr. T. Ravindranathan for the work on transition metal catalyzed asymmetric oxidations and reductions. From 1997 to 1998 he worked as a NIH postdoctoral fellow with Dr. Kenneth A. Jacobson in NIDDK, National Institutes of Health, USA, on the medicinal chemistry of nucleotide bis-phosphates as adenosine P2Y1-receptor antagonists. As an Alexander von Humboldt fellow at the Free University of Berlin, Germany, he was involved researching the SmI2-induced radical cyclization reactions toward synthesis of bioactive molecules. From 2001-2003 he pursued research in the development of molecular imaging probes for MRI, PET and SPECT with Dr. Henry F vanBrocklin at the Lawrence Berkeley National Laboratory, USA as a post-doctoral scientist. Before joining with IBN in 2004, he was working as a senior scientist at Molecular Therapeutics, Ann Arbor, USA, developing dynamic nanoparticle platforms for drug delivery and imaging of various diseases, especially cancer. He is currently working as a senior research scientist in the Nanobiotechnology group at A*STAR Institute of Bioengineering and Nanotechnology, Singapore.
Dr. Nandanan’s research is interdisciplinary in nature and his main interest focuses on how an organic chemist can solve the problems in biomedical as well as pharmaceutical research and development. His research interests include the development of novel targeted and induced drug delivery systems, practical in vivo imaging probes development, bio-conjugation and asymmetric organic synthesis for pharmaceuticals using nanotechnology. At IBN, he is mainly involved in the synthesis and development of supramolecular templated heterogeneous catalysts for pharmaceutical synthesis. The increase in demand for enantiomerically pure compounds in pharmaceuticals, agrochemicals, materials and fine chemicals drives his research for new homogeneous and heterogeneous catalysts that can perform more environmentally sustainable reactions with high efficiency and selectivity which are suitable in industrial applications. Dr. Nandanan has authored over 25 research articles in peer reviewed international journals and presented several posters at international conferences.
Dr. Nandanan has been recognized with a number of research fellowships, including CSIR junior and senior research fellowships, India; NIH visiting fellowship, USA; DOE-LBNL post-doctoral scientist fellowship, USA; and Alexander von Humboldt fellowship, Germany. He is an active member of both organic and medicinal chemistry divisions of the American Chemical Society. |
